parkinson glutathione oxidative ipsc crispr Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 | Journal of Molecular Medicine CRISPR And iPSC Disease Modeling
CRISPR And iPSC Disease Modeling And Drug Screening Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



